Strengths of the current study include being a first of its kind analysis, with the results being generalizable to the large component of the modern American population with overweight or obesity, metabolic syndrome components of elevated blood pressure, glucose intolerance, insulin insensitivity short of diabetes, and atherogenic dyslipidemia. The gene discussed is INS; the disease is obesity disorder.